Study of Antibody for Methamphetamine Outpatient Therapy

NCT03336866 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Methamphetamine-dependence
Methamphetamine Abuse

Interventions

DRUG: Placebo
DRUG: IXT-m200

Sponsor

InterveXion Therapeutics, LLC

Collaborators

[object Object]